The Indianapolis-based pharmaceutical giant said it plans to acquire ARMO BioSciences Inc., which is working on treatments that activate the immune system of cancer patients to recognize and eradicate tumors.
The money is designed to further the work of Dr. Burcin Ekser and his team, who are working to print three-dimensional pig liver tissue from genetically engineered pig liver cells.
The ads for the metastatic breast cancer drug Verzenio show women in their 50s and 60s looking resolute and indomitable, surrounded by smiling friends and family.
Shares in Athenahealth Inc. surged the most since 2016 after activist investor Elliott Management Corp. bid to acquire the medical company for $160 a share.
A five-year, $7 million program is led and supported by a coalition of local health institutions, including Eli Lilly and Co., Fairbanks School of Public Health and Eskenazi Health. It is based on a model that Lilly has used in other countries.
The Indianapolis pharmaceutical giant is evaluating whether to keep the division, which makes animal-health products, or sell it or take it public. An analyst said it might fetch $16 billion.
Indianapolis-based Eli Lilly and Co. on Tuesday reported quarterly revenue and adjusted earnings that exceeded analyst forecasts.
The plaintiffs—Planned Parenthood of Indiana and Kentucky, the American Civil Liberties Union and the ACLU of Indiana—called the measure "a cruel intimidation tactic."
The Health and Human Services funding is among $485 million recently awarded nationwide to combat heroin and opioid abuse.
Cigna Corp. confirmed that its proposed $54 billion acquisition of Express Scripts Holding Co. will be reviewed by the U.S. Department of Justice, which has raised the bar for approving deals that don’t combine direct competitors.
The number of prescriptions for opioid painkillers filled in the United States fell dramatically last year, showing their biggest drop in 25 years.
For more than a decade, Zeke Turner built scores of senior-care facilities. But in the past year, Mainstreet has been reeling from an unexpected slowdown in sales of its properties.
Jonathan Nalli has a message for his 16,000 employees at St. Vincent Health: Get ready for more transformation and disruption.
Indianapolis-based Hc1.com Inc., which sells customer-management software to health care enterprises, has raised three sizable rounds of capital in four years.
Insurance company Anthem Inc. has agreed to settle a federal lawsuit filed by Indiana parents who were denied coverage for therapy for their children with autism.
Drugmakers will have to offer a much more generous discount to Medicare beneficiaries who fall into the so-called donut hole coverage gap.
The Richard M. Fairbanks Foundation awarded $230,000 to the Indiana State Medical Association this week to develop the app and an accompanying podcast.
By the end of the year, officials expect to unveil its master plan to remake the state’s largest hospital—currently an amalgamation of ancient health care amenities and modern facilities.
Under the agreement, Lilly will pay Sigilon Therapeutics up to $410 million if the technology hits certain milestones.
The Indianapolis-based insurer is telling members that those small, freestanding hospitals are out of its network and could be much costlier to use.
